Nonthyroidal Illness

Suppression of the hypothalamic-pituitary-thyroid axis is an indicator for disease severity among people hospitalized with COVID-19, according to study data published in BMC Endocrine Disorders.

Physiologic variations in thyroid-stimulating hormone concentrations may lead to a misclassification of subclinical thyroid disease for some healthy pregnant women, possibly subjecting women to unnecessary treatment, researchers report.